Mental health conditions like severe anxiety, depression, and psychosis can affect women during pregnancy and the postnatal period. When non-pharmacological approaches are insufficient, psychotropic medications become necessary to stabilize the mother. Midwives in Nigeria frequently encounter pregnant and postpartum women managing pre-existing psychiatric conditions or experiencing new-onset disorders such as postpartum psychosis. Understanding how these drugs work helps midwives provide safe care, offer accurate reassurance, and avoid unnecessary panic or abrupt discontinuation of vital treatments.
Antipsychotic drugs are primarily used to treat schizophrenia, severe mood disorders, and postpartum psychosis. They are broadly divided into two generations:
Anxiolytic medications relieve severe anxiety, panic attacks, and sleep disturbances. In midwifery practice, they are used sparingly due to dependence risks.
Pregnancy alters how drugs are absorbed, distributed, metabolized, and excreted. Increased maternal blood volume, higher cardiac output, and faster liver metabolism mean that standard drug doses may result in lower blood levels. Conversely, as term approaches, drug clearance can shift again. Midwives should recognize that a pregnant woman stable on a specific dose of an antipsychotic may experience a relapse of psychiatric symptoms if her blood levels drop below the therapeutic window due to these expanded physiological volumes.
Most psychotropic medications readily cross the placenta. Exposure during the first trimester can carry theoretical risks of congenital malformations, though many modern antipsychotics and anxiolytics have reassuring safety profiles. Late-pregnancy exposure poses a different challenge: neonatal adaptation syndrome. Newborns exposed to antipsychotics or benzodiazepines near term may exhibit lethargy, poor feeding, abnormal muscle tone, or respiratory distress at birth. Midwives attending deliveries of women on these medications must collaborate closely with pediatric and neonatal nursing teams.
Many mothers wish to breastfeed while taking psychotropic medications. Almost all psychotropic drugs pass into breast milk, but the absolute amount the infant receives is usually a fraction of the maternal dose. Factors influencing infant safety include the drug's lipid solubility, half-life, and the baby's age and liver maturity. Medications like sertraline or certain atypical antipsychotics are often considered compatible with breastfeeding, while others require close infant monitoring for sedation or poor weight gain.
Midwives play a crucial frontline role in caring for women taking psychotropic drugs. Management involves taking a detailed medication history, coordinating with psychiatrists, and monitoring maternal mental and physical health. Midwives should never advise a woman to stop her psychiatric medication abruptly, as this triggers high relapse rates. Instead, they provide a non-judgmental environment, watch for metabolic side effects like excessive weight gain, and educate families on recognizing early warning signs of psychiatric deterioration.